Fabiane Sonego
Director of Preclinical Models & Services GenOway
Dr. Fabiane Sônego is an immunopharmacologist with extensive expertise in translational preclinical models for immunotherapy research. For more than a decade, she has collaborated with pharmaceutical companies, biotechnology firms, and academic researchers to support the selection and application of the most appropriate preclinical models for evaluating novel therapeutic approaches. Her expertise includes assessing model relevance and limitations to ensure the generation of robust, translatable data.
As Director of Preclinical Models & Services, she focuses on bridging scientific questions with the most predictive preclinical strategies, helping researchers investigate mechanisms of action, efficacy, and safety across a broad range of immunotherapies. Her goal is to enable informed decision-making and accelerate the development of innovative therapies through the use of reliable and translational preclinical models.
Seminars
- Robust human lymphoid and myeloid reconstitution without GvHD, enabling long-term immunotherapy studies.
- Clinically relevant B-cell depletion and T-cell pharmacodynamics with therapies targeting autoreactive B cells.
- Integrated efficacy and CRS-like safety assessment in a single translational platform.
